首页/数据集/KLF5 loss sensitizes to ATR inhibition and is synthetic lethal with ARID1A deficiency

KLF5 loss sensitizes to ATR inhibition and is synthetic lethal with ARID1A deficiency

ChEBI2024-12-09 更新2026-07-12 收录

肿瘤合成致死

基因靶向治疗

数据链接：

https://www.ebi.ac.uk/biostudies/ArrayExpress/studies/E-MTAB-14062 数据链接链接失效反馈

官方服务：

资源简介：

KLF5 loss sensitizes to ATR inhibition and is synthetic lethal with ARID1A deficiency

应用场景：

创建时间：

2024-12-09

前列腺癌治疗

基因靶向治疗

Enzalutamide (ENZ) is a potent androgen receptor (AR) antagonist with activity in castration-resistant prostate cancer (CRPC); however, progression to ENZ-resistant (ENZ-R) CRPC frequently occurs with

NIAID Data Ecosystem70

RNA enzyme-directed gene therapy.

RNA基因治疗

基因靶向治疗

RNA enzyme-directed gene therapy.

PubMed Central1993-12-01 更新30

Targeting the 3D genome by anthracyclines for chemotherapeutic effects

基因靶向治疗

蒽环类药物作用机制

The chromatins are folded into three-dimensional (3D) structures inside cells, which coordinates the regulation of gene transcription by the non-coding regulatory elements. Aberrant chromatin 3D foldi

NIAID Data Ecosystem30

sequencing of C57BL/6J male mice after injecting with APAP and treating with si-Cyp2e1 LNPs

药物性肝损伤模型

基因靶向治疗

C57BL/6J male mice were injected with 300 mg/kg APAP to establish DILI model and were given si-Cyp2e1 LNPs via the tail vein for treatment.

NIAID Data Ecosystem40

Supplemental Table 1. Functional delivery of splice shifting oligomer by nanoparticle type in the system described by Dean and Delong

纳米药物递送

基因靶向治疗

ABSTRACT Aims : To investigate the distribution, tolerance, and anticancer/antiviral activity of Zn-based physiometacomposites (PMCs). Methods : Manganese, iron, nickel and cobalt d

DataCite Commons2021-07-23 更新30

KLF5 loss sensitizes to ATR inhibition and is synthetic lethal with ARID1A deficiency

资源简介：

相关数据集